Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Research
Tobacco research group, genetics company set joint U.S. field trial experiment
August 18th, 2005
Icon Genetics announced a joint field trial experiment in collaboration with the Kentucky Tobacco Research and Development Center (KTRDC), University of Kentucky, Lexington. Transgenic plants with genetically engineered chloroplasts containing a phenylalanine ammonia lyase (PAL) gene from Arabidopsis thaliana will be tested under field conditions. A release permit has been obtained from APHIS, the United States Department of Agricultures' Animal and Plant Health Inspection Service. An overexpression of the PAL gene in tobacco chloroplasts aims at both pharmaceutical and industrial applications: the purified enzyme can serve as a drug for the...
Source: Women's Health Weekly (2005-08-18)
|
